<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC. 20549
FORM 10-QSB
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1999
ZAXIS INTERNATIONAL INC.
(Name of Issuer as specified in its charter)
Delaware 0-15476 68-0080601
(State of Incorporation) (Commission File Number) (IRS Employer
Identification No.)
1890 Georgetown Road, Hudson Ohio 44236
(Address of principal executive office)
(330) 650-0444
(Registrant's telephone number)
Check whether the registrant (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months and (2) has
been subject to such filings for the past 90 days. Yes[X] No [ ]
As of September 30, 1999, there were 6,291,306 shares of Common Stock
outstanding.
Page 1 of 16
<PAGE> 2
ZAXIS INTERNATIONAL INC.
FORM-1O-QSB
INDEX
<TABLE>
<CAPTION>
Page No.
<S> <C>
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
Consolidated Balance Sheets as of September 30, 1999 and December 31, 1998...................3
Consolidated Statements of Operations:
Quarters ended September 30, 1999 and 1998.................................4
Nine Months ended September 30, 1999 and 1998..............................5
Consolidated Statements of Stockholders' Deficiency................................6
Consolidated Statements of Cash Flows..............................................7
Notes to Consolidated Financial Statements........................................8
Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations for the Nine Months Ended September 30, 1999.............9
PART II. OTHER INFORMATION
Item 1. Not Applicable
Item 2. (c) Changes in Securities..................................................9
Item 3. Defaults upon Senior Securities...........................................10
Item 4. Not Applicable
Item 5. Other Information ........................................................10
Item 6. Exhibits and Reports on Form 8-K .........................................11
SIGNATURES..................................................................................11
EXHIBIT.....................................................................................12
</TABLE>
Page 2 of 16
<PAGE> 3
ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
ASSETS
------
<TABLE>
<CAPTION>
SEPTEMBER 30, DECEMBER 31,
1999 1998
------------- ------------
(UNAUDITED) (AUDITED)
<S> <C> <C>
CURRENT ASSETS:
Cash $ 12,298 $ 49,327
Accounts receivable, net 39,271 13,904
Inventory 83,463 64,738
Prepaid expenses and other 27,367 29,671
----------- -----------
Total current assets 162,399 157,640
PROPERTY AND EQUIPMENT:
Machinery and equipment 362,231 360,082
Office equipment 190,064 190,064
Leasehold improvements 86,992 86,992
----------- -----------
639,287 637,138
Less accumulated depreciation 472,566 400,731
----------- -----------
166,721 236,407
OTHER ASSETS:
Patent costs 35,019 37,910
Organization costs -- 395
----------- -----------
35,019 38,305
----------- -----------
TOTAL ASSETS $ 364,139 $ 432,352
=========== ===========
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
----------------------------------------
CURRENT LIABILITIES:
Current portion of lease obligations $ 11,742 $ 10,906
Notes payable to directors 1,157,987 784,895
Notes payable 306,928 475,264
Accounts payable 577,910 476,962
Accrued expenses 670,063 449,341
----------- -----------
Total current liabilities 2,724,630 2,197,368
LONG TERM LIABILITIES:
Capitalized lease obligations 19,845 28,706
Notes payable -- 130,000
Notes payable to directors 613,712 684,012
----------- -----------
Total long term liablilites 633,557 842,718
STOCKHOLDERS' DEFICIENCY:
Common stock 64,637 58,112
$.01 par value, 12,000,000 shares authorized,
6,463,667 shares issued and issuable at June 30, 1999
5,811,216 shares issued and outstanding at December 30, 1998
Additional paid-in capital 6,590,285 5,984,885
Accumulated deficit (9,648,970) (8,650,731)
----------- -----------
Total stockholders' deficiency (2,994,048) (2,607,734)
----------- -----------
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 364,139 $ 432,352
=========== ===========
</TABLE>
See notes to consolidated financial statements.
Page 3 of 16
<PAGE> 4
ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
UNAUDITED
<TABLE>
<CAPTION>
THREE MONTHS ENDED
SEPTEMBER 30
---------------------------
1999 1998
----------- -----------
<S> <C> <C>
Net sales $ 84,345 $ 58,130
Operating Costs:
Cost of goods sold 98,974 129,098
Selling, general, administrative and research expenses 227,006 203,232
----------- -----------
325,980 332,330
----------- -----------
Loss from operations (241,635) (274,200)
Other income (expense):
Interest expense (49,653) (41,819)
Other, net 17 550
----------- -----------
Total other income (expense) (49,636) (41,269)
----------- -----------
Net loss $ (291,271) $ (315,469)
=========== ===========
Net loss per common share -- Basic and Diluted $ (0.05) $ (0.05)
=========== ===========
Weighted average number of shares outstanding -- Basic and Diluted 6,463,667 5,763,299
=========== ===========
</TABLE>
See notes to consolidated financial statements.
Page 4 of 16
<PAGE> 5
ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
UNAUDITED
<TABLE>
<CAPTION>
NINE MONTHS ENDED
SEPTEMBER 30
----------------------------
1999 1998
----------- -----------
<S> <C> <C>
Net sales $ 176,496 $ 153,518
Operating Costs:
Cost of goods sold 359,972 410,398
Selling, general, administrative and research expenses 666,025 584,963
----------- -----------
1,025,997 995,361
----------- -----------
Loss from operations (849,501) (841,843)
Other income (expense):
Interest expense (148,961) (117,237)
Other, net 223 6,894
----------- -----------
Total other income (expense) (148,738) (110,343)
----------- -----------
Net loss $ (998,239) $ (952,186)
=========== ===========
Net loss per common share -- Basic and Diluted $ (0.16) $ (0.17)
=========== ===========
Weighted average number of shares outstanding -- Basic and Diluted 6,231,813 5,763,299
=========== ===========
</TABLE>
See notes to consolidated financial statements.
Page 5 of 16
<PAGE> 6
ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY
<TABLE>
<CAPTION>
COMMON STOCK
---------------------------- ADDITIONAL TOTAL
NUMBER OF STATED OR PAID-IN ACCUMULATED STOCKHOLDERS'
SHARES PAR VALUE CAPITAL DEFICIT DEFICIENCY
----------- ----------- ----------- ----------- -----------
<S> <C> <C> <C> <C> <C>
Balance at December 31, 1998 5,811,216 $ 58,112 $ 5,984,885 $(8,650,731) $(2,607,734)
Sales of shares, including conversion of
notes payable 641,733 6,418 601,831 608,249
Shares issued due to stock option grants 10,718 107 3,569 3,676
Net loss for the period (998,239) (998,239)
----------- ----------- ----------- ----------- -----------
Balance at September 30, 1999 6,463,667 $ 64,637 $ 6,590,285 $(9,648,970) $(2,994,048)
</TABLE>
See notes to consolidated financial statements.
Page 6 of 16
<PAGE> 7
ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
NINE MONTHS ENDED TWELVE MONTHS ENDED
SEPTEMBER 30, DECEMBER 31,
------------ -------------
1999 1998
------------ ------------
(UNAUDITED) (AUDITED)
<S> <C> <C>
Operating activities:
Net loss $ (998,239) $(1,285,053)
Adjustments to reconcile net loss to cash
used in operating activities:
Depreciation and amortization 76,020 119,678
Compensation due to stock option grants 3,676 39,773
Changes in operating assets and liabilities:
Accounts receivable (25,367) 25,167
Inventory and prepaid expenses (16,421) (1,181)
Accounts payable and accrued expenses 321,666 273,463
----------- -----------
Cash used in operating activities (638,665) (828,153)
INVESTING ACTIVITIES:
Purchase of property and equipment (2,149) (7,569)
Patent cost expenditures (897) (2,243)
----------- -----------
Cash used in investing activities (3,046) (9,812)
FINANCING ACTIVITIES:
Proceeds from sales of common stock 608,253 --
Net proceeds from notes payable 4,453 815,272
Payments on capital lease obligations (8,024) (9,390)
----------- -----------
Cash provided by financing activities 604,682 805,882
----------- -----------
Increase (Decrease) in cash (37,029) (32,083)
Cash at beginning of period 49,327 81,410
----------- -----------
Cash at end of period $ 12,298 $ 49,327
=========== ===========
</TABLE>
See notes to consolidated financial statements.
Page 7 of 16
<PAGE> 8
ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
The financial statements present the consolidated financial position and results
of operations of Zaxis International Inc. (International) and Zaxis Inc. (Zaxis
or the Company) its wholly-owned subsidiary.
Zaxis Inc. was founded in 1989 as a privately held Ohio corporation. On August
25, 1995, Zaxis merged with a subsidiary of The InFerGene Company (InFerGene).
InFerGene was an inactive publicly traded Delaware corporation founded in 1985.
Neither InFerGene nor its subsidiary had any assets or liabilities. The merger,
for accounting purposes, was a reverse acquisition in which Zaxis acquired
InFerGene. The acquisition was accounted for as a purchase with no value
assigned to InFerGene. InFerGene then changed its name to Zaxis International
Inc. The financial statements include the operations of Zaxis for all periods
presented and the operations of International since the date of acquisition. All
intercompany transactions and balances have been eliminated.
The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. Operating results for the three- and nine-month periods
ended September 30, 1999 are not necessarily indicative of the results that may
be expected for the year ended December 31, 1999.
The consolidated balance sheet and consolidated statements of cash flow at
December 31, 1998 have been derived from the audited financial statements at
that date but does not include all of the information and footnotes required by
generally accepted accounting principles for complete financial statements.
For further information, refer to the consolidated financial statements and
footnotes thereto included in the Registrant Company and Subsidiaries' annual
report on Form 10-K for the year ended December 31, 1998.
2. COMMON STOCK AND WARRANTS
During the nine months ended Septermber 30, 1999, Zaxis International Inc., in
connection with an ongoing private offering of securities, obtained
subscriptions for a total of 608,249 units at $1.00 per unit; each unit
consisting of one share of common stock and Class Z, Series Z-3, Z-4, Z-5, and
Z-6 Warrants entitling the holder in the aggregate to purchase one additional
share of common stock. As of September 30, 1999, $284,241 had been received in
cash and $324,008 of principal and accrued interest of notes payable had been
converted; also, as of that date, 435,888 shares of common stock had actually
been issued and the balance of 172,361 shares were still to be issued.
3. LIQUIDITY
Zaxis incurred losses of $998,239 during the nine months ended September 30,
1999, and $952,186 in 1998. The operations of the Company have been financed
mainly by loans from companies and individuals associated with members of the
Board of Directors.
Page 8 of 16
<PAGE> 9
The Company continues to rely upon these sources to sustain on-going operations,
research, production development and sales development. Discussions have been
conducted with potential new investors for long-term debt or equity funding. The
Company will necessarily be reliant upon such sources of funding until the
marketing of the companies' principal products can be brought to a level
sufficient to support the operating requirements of the Company. These
conditions cause doubt about the Company's ability to continue as a going
concern. No adjustments to the amounts or classification of assets and
liabilities which could result from the outcome of this uncertainty are
reflected in the financial statements.
4. NET LOSS PER COMMON SHARE
The effects of outstanding options and warrants have not been included in the
calculation of net loss per share.
PART I. FINANCIAL INFORMATION
Item 2. Management's Discussion and Analysis.
Management's Discussion and Analysis of Financial Condition and Results of
Operations for the Nine- Months Ended September 30, 1999.
RESULTS OF OPERATIONS
Sales for the third quarter totaled $84,345 as compared with $58,130 for 1998's
third quarter. Sales for the nine months ended September 30, 1999, were $176,496
as compared to $153,518 for the same period last year.
Operating costs were $325,980 for the third quarter of 1999 as compared with
$332,330 for the same period last year. Operating costs for the nine months
ended September 30, 1999, were $1,025,997 as compared with $995,361 for the
first nine months of 1998.
Interest expense increased due to increased borrowings.
Net loss for the third quarter amounted to $291,271 as compared to a net loss of
$315,469 for the same quarter of 1998. The net loss for the nine months ended
September 30, 1999, was $998,239 and compares to a net loss of $952,186 for the
same period last year.
FINANCIAL CONDITION AND LIQUIDITY
Cash used for operations amounted to $638,665 for the nine months ended
September 30, 1999. Plant and equipment expenditures amounted to $2,149. Cash
provided from financing activities, including the sale of additional
unregistered securities amounted to $604,682 for the nine months ended September
30, 1999. The Company is reliant upon investors to provide funds for operations
and is working to maintain steady relations with its creditors while it strives
to improve sales volumes and to demonstrate that the Company can be successful.
Page 9 of 16
<PAGE> 10
The Company needs to secure additional immediate financing to allow it to
explore several opportunities from new products that are now available for
market introduction and to afford it time to build sales volumes of these new
products to profitable levels. In the period required for product introduction
and sales growth, the Company will also need to satisfy obligations to current
creditors. Pursuant to this need, the Company continues to seek interim and
long-term debt or equity funding.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
None of substantial nature.
Item 2(c). Changes in Securities--Recent Issuances of Unregistered Securities
During the period ended September 30, 1999, in transactions exempt from
registration, Zaxis International Inc. sold 608,249 shares (of which 172,361
shares were still to be issued as of September 30, 1999) of Common Stock valued
at $1.00 per share in exchange for cash ($284,241) and Convertible Notes and
related accrued interest ($324,008). In addition, 10,718 shares of Common Stock
were issued as a result of the exercise of stock options.
Item 3. Default upon Senior Securities
The company is more than 30 days past due on principal payment on three
individual C series notes totaling $65,000. The Company is more than 30 days
past due on interest payments on above referenced C series notes and 9 1/2%
Convertible notes in the aggregate amount of $301,743. The Company is more than
30 days past due on $475,000 on principal on various notes, plus interest, due
to MML Manangement Ltd., and Australian based investment firm, and to funds
managed by MML. The management of MML is a related party. The Managing Partner
of MML is Alan Scott, who is a director of Zaxis and is Managing Director of
Progen Industries Ltd., the largest single shareholder in the Company. The other
partner in MML is Craig Jones, also a director of Zaxis. Included in the notes
in default is an MML loan of $65,000 secured by the Company's accounts
receivable and a patent owned by the Company.
Item 4. Submission of Matters to a Vote of Security Holder
No matters were submitted to a vote of security holders during the
nine months ended September 30, 1999.
Item 5. Other Information
Subsequent Events
The Company, the Directors of the Company, and the principal executive
of the Company have entered into a multi-step agreement that provides for
additional funding and board and management changes for the Company.
The agreement, styled Termination of Consulting Agreement and Full and
Final Release, provides for additional funding to the Company of $390,000 by
mid-December. The Company
Page 10 of 16
<PAGE> 11
has received $90,000 of this amount. The agreement was approved at the November
15, 1999 board meeting and subsequently amended by Unanimous Written Consent
Resolution dated November 21, 1999.
For the Agreement to be effective, the Company must receive new
fundings of $90,000 in 90-day loans with conversion rights and $300,000 in new
equity funds. The $90,000 in notes funding had to be, and was completed by
November 29 for the Agreement to remain in effect. The $300,000 in equity
funding must be completed no later than the 11th day after the date of a revised
confidential offering memorandum for the Agreement to remain in effect. The
Company anticipates that this revised Confidential Offering Memorandum will be
issued by December 1, 1999.
If the funding levels in the Agreement are met and the other conditions
in the Agreement are met, then the President/Chief Executive Officer will resign
and the present five members of the Board of Directors will resign and elect a
new Board of five directors. The Directors have agreed that no current board
member will be elected to the successor board. The new board will be charged
with selection of a principal executive officer. All Directors have signed the
Agreement and have submitted their resignations in writing, to be effective upon
the satisfaction of the conditions described in the Agreement, a copy of which
is the exhibit on pages 12-16.
The Agreement does not provide for alternative action if the additional
funding, which required to maintain operations, is not provided.
Item 6. Exhibits and Reports on Form 8-K
A. Exhibits:
Termination of Consulting Agreement and Full and Final Release
B. Reports on Form 8-K during the Quarter Ended September 30, 1999:
None
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf the undersigned, thereunto duly
authorized.
Zaxis International Inc.
---------------------------
(Registrant)
November 30, 1999 BY: S/S Conaly Bedell
-----------------------
Conaly Bedell, President
Chief Executive Officer
Page 11 of 16
<PAGE> 12
TERMINATION OF CONSULTING AGREEMENT
AND FULL AND FINAL RELEASE
(As amended by November 21, 1999 Unanimous Written Action of the
Board of Directors)
In consideration of the performance of the agreements set forth below,
each of Conaly Bedell of 720 South 25th Street, Fort Smith, Arkansas 72901
("BEDELL"), Bedell Inc., an Arkansas corporation with an office at 720 South
25th Street, Fort Smith, Arkansas 72901 ("CONSULTANT", for convenience BEDELL
and BEDELL INC are sometimes referred to collectively as "BEDELL") for himself,
itself and, as appropriate, his or its heirs, personal representatives,
successors and assigns and ZAXIS International, Inc., a Delaware corporation
with its principal office at 1890 Georgetown, Road, Hudson Ohio 44236 ("ZAXIS"),
for itself, its individual directors, and its successors and assigns, fully and
forever releases, acquits and discharges the other(s) and their respective
officers, directors, agents, representatives, subsidiaries, divisions,
affiliated companies (including ZAXIS, Inc.), successors, assigns, heirs and
personal representatives, from any and all claims, demands, actions and causes
of action of every kind, nature or description which any of them may have had,
may now have or may hereafter have against the other(s) by reason of any matter,
cause, act or omission arising out of or in connection with BEDELL's performance
of services under the Consulting Agreement between CONSULTANT and ZAXIS, dated
February 5, 1997 ("Consulting Agreement") (but not the performance of
obligations under this Agreement), including Conaly Bedell's services as a
director, chairman of the board, president and chief executive officer of ZAXIS
and/or the termination of the Consulting Agreement, including but not limited
to:
(a) claims, actions, causes of action or liabilities and/or any
other federal, state, or local statute, law, ordinance or
regulation; and/or
(b) any other claim whatsoever including, but not limited to,
claims based upon breach of contract, wrongful termination,
defamation, intentional infliction of emotional distress,
negligence and/or any other common law, statutory or other
claim whatsoever arising out of or relating to BEDELL's
performance under the Consulting Agreement and/or the
termination thereof.
1. TERMINATION OF CONSULTING AGREEMENT. ZAXIS and BEDELL agree that the
Consulting Agreement, as modified by this Agreement, will terminate on the
thirtieth day after the date of this Agreement or such other date as may be
agreed by BEDELL and the then current senior officer of ZAXIS ("Termination
Date") and that performance by the parties of his or its obligations under this
Agreement constitutes full satisfaction of all claims and obligations under the
Consulting Agreement. Until the Termination Date, BEDELL will continue to
provide services under the Consulting Agreement as requested by the then senior
officer of ZAXIS, but Conaly Bedell shall not be required to make more than two
trips outside Fort Smith, Arkansas. Notwithstanding the termination of the
Consulting Agreement, the provisions of Section 3, 4, 5, 6 and 8 of the
Consulting Agreement shall apply to both Conaly Bedell and CONSULTANT and shall
survive termination in accordance with their terms.
2. RESIGNATION. Conaly Bedell's execution of this Agreement constitutes
Conaly Bedell's resignation as a director, chairman of the board, president and
chief executive officer of ZAXIS, effective on the date that the last of the
following are delivered as follows:
Page 12 of 16
<PAGE> 13
(a) to Conaly Bedell:
1. Promissory Note in principal amount of $60,000 as described in
Section 6 (b)
2. Letter of credit described in Section 6 (b)
3. Grants of stock options described in Section 5
4. Executed letter addressed to Zaxis transfer agent directing the
issuance of 6,000 shares of Common Stock of Zaxis as described in Section 6 (b)
5. Executed letter addressed to Zaxis' transfer agent directing the
issuance of 12,191 shares of Common Stock of Zaxis as described in Section 7 (a)
6. Zaxis shall have received the following:
(A) A written commitment to provide Fifty Thousand Dollars
($50,000) of funding by the end of business (5:00 p.m. EST) on
Tuesday, November 16, 1999;
(B) Pursuant to the commitment in Section 2 (a) 6. (A): (i)
Fifty Thousand Dollars ($50,000) in immediately available
funds by noon on Monday, November 22, 1999, such funding to be
evidenced by the issuance by Zaxis of one or more notes in the
aggregate principal amount of Fifty Thousand Dollars ($50,000)
bearing simple annual interest at a rate not to exceed Ten
Percent (10%) per annum ("November 22 Note(s)"); and (ii) as
an additional condition on the effectiveness of this
Agreement, Zaxis shall have received an additional Forty
Thousand Dollars ($40,000) in immediately available funds by
noon on Monday, November 29, 1999, such funding to be
evidenced by the issuance by Zaxis of one or more notes in the
form of the Note in aggregate principal amount of Forty
Thousand Dollars ($50,000) ("November 29 Note(s)"); and the
officers of the Company are authorized to deliver to the
providers of such funding the written agreement of Zaxis to
permit the lender(s): (i) to convert the November 22 Note(s)
on the terms of the current Confidential Offering Memorandum
and to purchase an additional Fifty Thousand Dollars ($50,000)
of securities of Zaxis on the terms of the current
Confidential Offering Memorandum within ninety (90) days after
the lender(s) convert the November 22 Note(s) in payment of
such securities; and (ii) to convert the November 29 Note(s)
on the terms of the current Confidential Offering Memorandum
and to purchase an additional Forty Thousand Dollars ($40,000)
of securities of Zaxis on the terms of the current
Confidential Offering Memorandum within ninety (90) days after
the lender(s) convert the November 29 Note(s) in payment of
such securities; and
(C ) No less than Three Hundred Thousand Dollars ($300,000) in
new equity funding by Noon on the eleventh calendar day
following the date shown as the date of a revised Confidential
Offering memorandum which includes the Company's 10-Q report
for the quarter ending September 30, 1999 as filed with the
Securities and Exchange Commission.
Page 13 of 16
<PAGE> 14
7. The written resignations of each of Directors Leonard A. Duval,
Craig Jones, Alan Scott and Calvin Wible, such resignations by their
terms to be effective upon the holding of a meeting of the Board of
Directors at which each of the five current Directors of Zaxis resigns
upon the election as a director of a successor (who shall not be one of
the five current Directors) to be nominated by the resigning Director
and in the form of Exhibit A to this Agreement. At the meeting held
pursuant to the foregoing resignations, Conaly Bedell shall deliver the
four resignations to the Corporate Secretary for retention with the
Zaxis minute book. By their execution of this Agreement each of Conaly
Bedell, Leonard A. Duval, Craig Jones, Alan Scott and Calvin Wible
agrees that the first order of business at the Board meeting to be held
as soon as the funding described in Section 2. (a) 6 has been received
by Zaxis (or as soon thereafter as a quorum is available) will be the
election of new Directors and that he will vote for the successor
Director nominated by each other Director (provided that none of the
nominees for election is a current director). In light of the
resignation of the Chairman, the meeting will be convened by the
Corporate Secretary who will act as chairman until a new board is
elected and has elected a chairman of the Board.
(b) To James J. Branagan, counsel for Zaxis, the four executed checks
dated as described in Section 6 (a). Mr. Branagan is hereby directed to
mail these checks to Conaly Bedell at the address listed above two days
before the respective dates on which the checks are payable.
3. TERMS CONFIDENTIAL. The parties understand and agree that the terms
of the Agreement, including the payments made to BEDELL, will be confidential
and will not be divulged to any third party other than his or its attorney and
other professional advisors without the prior written consent of the other
party.
4. NO ANNOUNCEMENTS. No party will issue written or oral communications
derogatory of the other. No party will issue any written or oral communication
regarding this Agreement, except for accurate statements made pursuant to
regulatory (including Securities Exchange Commission) requirements, to subpoena
or interrogation by governmental agencies.
5. STOCK OPTIONS. Conaly Bedell currently holds options to purchase
54,578 shares of Common Stock of ZAXIS, which number includes stock options
earned by Conaly Bedell for services through June 30, 1999 under Section 2.(b)
of the Consulting Agreement. For services from July 1, 1999 through November 15,
1999 Conaly Bedell is entitled to options to purchase 11,485 additional shares
of Common Stock of Zaxis. For services to be rendered by BEDELL between November
15, 1999 and the Termination Date, Zaxis shall issue to Conaly Bedell additional
options for 1,000 shares of Common Stock of Zaxis pursuant to Section 2.(b) of
the Consulting Agreement. None of the foregoing options to purchase Common Stock
of Zaxis shall be affected by this Agreement.
6. PAYMENT. Zaxis shall make the following payments to BEDELL:
(a). FUTURE CONSULTING SERVICES. For services to be rendered under the
Consulting Agreement between the date hereof and the Termination Date,
Ten Thousand Dollars ($10,000) payable in four equal installments of
Two Thousand Five Hundred Dollars
Page 14 of 16
<PAGE> 15
($2,500) payable on each of November 19, 1999, November 26, 1999,
December 3, 1999 and December 10, 1999.
(b). PAST CONSULTING SERVICES. For services rendered under the
Consulting Agreement prior to the date hereof, Sixty Thousand Dollars
($60,000) and Six Thousand shares of Common Stock of Zaxis
("Termination Amount"). The Termination Amount shall be paid by the
delivery to BEDELL of: (1) a promissory note of Zaxis ("Note") in
principal amount equal to Sixty Thousand Dollars, and shall bear
interest on the unpaid balance from time to time outstanding at the
simple annual rate equal to the prime rate of interest charged by
KeyBank of Cleveland and (2) Six Thousand shares of Common Stock of
Zaxis. Principal on the Note shall to be paid in twenty four equal
installments of Two Thousand Five Hundred Dollars ($2,500) commencing
on the Termination Date and thereafter on the same date in each of the
following twenty-three months. Each monthly payment shall include
interest on the unpaid balance. The Note shall be secured by a letter
of credit issued by a national bank in favor of BEDELL in amount equal
to the original principal amount of the Note and shall provide that
upon the issuing bank's receipt of written evidence of default in the
payment of principal or interest under the Note, the issuing bank will
pay to BEDELL the unpaid principal amount of the Note. The letter of
credit shall be delivered at the time of execution of this Agreement.
Upon the written consent of the parties, other security may be
substituted for the letter of credit.
7. OTHER MATTERS.
(a) ISSUANCE OF SHARE CERTIFICATE. Within fifteen days after the
execution of this agreement ZAXIS shall cause the transfer agent to
issue to Conaly Bedell a certificate for Twelve Thousand One Hundred
Ninety-One (12,191) shares of Common Stock of ZAXIS, the issuance of
which was previously approved and authorized, but which has not been
completed.
(b) DELIVERY OF PROPERTY. Upon execution of this Agreement BEDELL shall
deliver to ZAXIS all property of any type or kind owned by or leased to
ZAXIS.
(c) THIRD PARTY RELEASE. Commencing on the date of execution of this
Agreement ZAXIS shall use its best efforts to arrange for the execution
of a mutual release by Conaly Bedell and John Russo, which release
shall follow the general form of the release in the first paragraph of
this Agreement.
(d) INDEMNIFICATION. The parties acknowledge and agree that this
Agreement shall have no affect on the obligations of Conaly Bedell and
ZAXIS under the director and officer indemnification provisions of
Delaware law and the By-Laws of Zaxis.
8. GOVERNING LAW. Except for matters of corporate law, which are
governed by the laws of Delaware, the state of incorporation of ZAXIS, this
Agreement will be interpreted pursuant to the laws of the State of Ohio and is
binding on the parties hereto, their heirs, personal representatives, successors
and assigns, including any successor to the business of ZAXIS.
Page 15 of 16
<PAGE> 16
IN WITNESS WHEREOF, each of Conaly Bedell, Bedell Inc., and ZAXIS has
executed this Termination of Consulting Agreement and Full and Final Release
personally or by its duly authorized officer, this 16th day of November, 1999,
and acknowledges that he/it executed the same as his/its own free act and deed.
ZAXIS INTERNATIONAL, INC. BEDELL, Inc.
/s/ Conaly Bedell
-------------------------------
By: All Directors, Other than Conaly Bedell By: CONALY BEDELL
Its: President
/s/ Calvin Wible
- ----------------------------------
Calvin Wible
/s/ Leonard A. Duval /s/ Conaly Bedell
- ---------------------------------- -------------------------------
Leonard A. Duval CONALY BEDELL
/s/ Craig Jones
- ----------------------------------
Craig Jones
/s/ Alan Scott
- ----------------------------------
Alan Scott
Page 16 of 16
